title: Insulin resistance determines efficacy of glimepiride in Type 2 diabetic patients not well controlled by diet alone.
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Shimizu
authors.forename: Takeshi
authors.initials: T
authors.lastname: Monden
authors.forename: Takashi
authors.initials: T
authors.lastname: Nagai
authors.forename: Yoshihito
authors.initials: Y
authors.lastname: Shoda
authors.forename: Tetsurou
authors.initials: T
authors.lastname: Sato
authors.forename: Masanobu
authors.initials: M
authors.lastname: Yamada
authors.forename: Masatomo
authors.initials: M
authors.lastname: Mori
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance; D008297:Male; D008875:Middle Aged; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin; D013453:Sulfonylurea Compounds; C057619:glimepiride